Inteleos and Dr. Smile Medical Group Form Partnership to Support Development of Global Standards for CHIVA
June 4, 2026
Rockville, MD, Washington D.C. and Shanghai China, Monday, May 17, 2021 –– Inteleos and Shanghai Dr. Smile Medical Technologies Co. Ltd. (Dr. Smile Medical Group) have signed a Memorandum of Understanding (MOU) to form the long-term strategic partnership and initiate a pilot program of global CHIVA standards and certification development. On May 14, over 100 people around the globe gathered to launch the long-term strategic partnership and initiate a pilot program of global CHIVA standards and certification development. The audience represented experts from: France, Italy, Germany, Brazil, Colombia, Argentina, Romania, Spain, China, and the United States.
CHIVA is the French acronym for “Cure conservatrice et Hemodynamique de l’Insuffisance Veineuse en Ambulatoire” (Conservative and Hemodynamic treatment of Venous Insufficiency in outpatients). CHIVA was first described by Claude Franceschi in 1988 and is an alternative to common procedures for varicose veins. The aim of the technique is to lower transmural pressure in the superficial venous system and avoid destruction of veins while decreasing pain, cost, and nerve damage…
Related News
Portal Upgrade FAQ: What is changing?
Inteleos Names First Chief Product Officer to Lead New Healthcare Innovation Division
American Physical Therapy Association and Inteleos Activate Partnership with First Joint Educational Program for Musculoskeletal Ultrasound Imaging Standards and Certification
Get in Touch
Reach out to learn more about Inteleos and our communities
"*" indicates required fields